Related Experiment Video
Updated: Jan 16, 2026
A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular Therapeutic
Keertana Yalamanchili1,2, Mark Broadwin1,2, Dwight D Harris1,2
1Cardiovascular Research Center, Rhode Island Hospital, Providence, RI 02903, USA.
Abstract:
JP4-039, a mitochondrial-targeted nitroxide, has emerged as a promising candidate in addressing the intricate interplay of reactive oxygen species (ROS) in cardiovascular disease (CVD). Given the substantial mortality and economic burden associated with CVD globally, novel therapeutic strategies targeting oxidative stress hold significant promise. The pathophysiology of CVD encompasses multifaceted mechanisms, including endothelial dysfunction, inflammation, and oxidative stress, where dysregulated ROS levels play a pivotal role. JP4-039, by selectively targeting mitochondrial ROS, offers a targeted approach to mitigate oxidative stress-induced damage in cardiovascular tissue. Current research elucidates the molecular mechanisms underlying JP4-039's antioxidant properties, including its ability to scavenge superoxide radical anions and mitigate oxidative chain reactions within mitochondria. Moreover, preclinical studies highlight JP4-039's efficacy in ameliorating CVD-related pathologies, including atherosclerosis and cardiac hypertrophy, through its antioxidative and anti-inflammatory effects. Future milestones in JP4-039 research involve optimizing its pharmacokinetic (PK) properties and exploring potential synergistic effects with existing cardiovascular therapies, followed by advancing into clinical trials.
Insights
JP4-039, a novel mitochondrial-targeted nitroxide, shows promise in treating cardiovascular disease (CVD) by reducing harmful reactive oxygen species (ROS). Preclinical studies demonstrate its potential to combat atherosclerosis and cardiac hypertrophy, paving the way for clinical trials.
Area of Science:
- Biomedical Science
- Cardiovascular Research
- Mitochondrial Medicine
Background:
- Cardiovascular disease (CVD) presents a significant global health challenge, characterized by complex pathophysiology involving endothelial dysfunction, inflammation, and oxidative stress.
- Dysregulated reactive oxygen species (ROS) levels, particularly within mitochondria, are central to CVD progression.
- Novel therapeutic strategies targeting mitochondrial oxidative stress are crucial for effective CVD management.
Purpose of the Study:
- To investigate the potential of JP4-039, a mitochondrial-targeted nitroxide, as a therapeutic agent for cardiovascular disease (CVD).
- To elucidate the antioxidant and anti-inflammatory mechanisms of JP4-039 in mitigating cardiovascular pathologies.
- To evaluate the preclinical efficacy of JP4-039 in relevant CVD models.
Main Methods:
- Characterization of JP4-039's antioxidant properties, focusing on its ability to scavenge mitochondrial ROS, specifically superoxide radical anions.
- Assessment of JP4-039's capacity to interrupt mitochondrial oxidative chain reactions.
- Preclinical evaluation of JP4-039's therapeutic effects in models of atherosclerosis and cardiac hypertrophy.
Main Results:
- JP4-039 effectively targets mitochondrial ROS, demonstrating potent antioxidant capabilities.
- Preclinical studies confirmed JP4-039's efficacy in ameliorating atherosclerosis and cardiac hypertrophy.
- Evidence suggests JP4-039 exerts both antioxidative and anti-inflammatory effects, contributing to its cardioprotective actions.
Conclusions:
- JP4-039 represents a promising therapeutic candidate for cardiovascular diseases by selectively targeting mitochondrial oxidative stress.
- Further research focusing on optimizing JP4-039's pharmacokinetic properties and exploring synergistic effects with existing therapies is warranted.
- Advancement of JP4-039 into clinical trials is a key future milestone for validating its therapeutic potential in human cardiovascular conditions.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:45Mitochondrial Membranes
01:30Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
01:24Peroxisomes